Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of chronic he1patitis C genotype 1 with peginterferon-alpha2a (40 kDa) plus ribavirin under routine clinical practice in Spain: early prediction of sustained virological response rate.
Diago M, Olveira A, Solá R, Romero-Gómez M, Moreno-Otero R, Pérez R, Salmerón J, Enríquez J, Planas R, Gavilán JC, Del Olmo J, Uribarrena R, Sillero C, Benítez A, Sánchez-Galdón S, Dalmau B, Eraña L, Montoro M, Portu J, Garijo JM, Barniol R, Domínguez A, Rota R, Olcoz JL, Antón M, Pamplona X, Casanovas T, Jiménez E, Huarte M, Díaz F, Sánchez-Ruano J, Orive M, Muñoz-Sánchez M, Roset M. Diago M, et al. Among authors: olcoz jl. Aliment Pharmacol Ther. 2007 Apr 15;25(8):899-906. doi: 10.1111/j.1365-2036.2007.03270.x. Aliment Pharmacol Ther. 2007. PMID: 17402993 Clinical Trial.
Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C.
Pérez R, Jiménez M, Crespo J, Diago M, Enríquez J, Vaquero P, Solá R, Olcoz JL, Romero M, Salmerón J, Blanco MI, Oña M, Melón S, Rodrigo L; Grupo Inter-Hospitalario Español. Pérez R, et al. Among authors: olcoz jl. J Viral Hepat. 2003 Nov;10(6):437-45. doi: 10.1046/j.1365-2893.2003.00461.x. J Viral Hepat. 2003. PMID: 14633177 Clinical Trial.
Usefulness of combined measurement of serum bile acids and ferritin as additional prognostic markers to predict failure to reach sustained response to antiviral treatment in chronic hepatitis C.
Jorquera F, Monte MJ, Guerra J, Sanchez-Campos S, Merayo JA, Olcóz JL, González-Gallego J, Marin JJ. Jorquera F, et al. Among authors: olcoz jl. J Gastroenterol Hepatol. 2005 Apr;20(4):547-54. doi: 10.1111/j.1440-1746.2005.03725.x. J Gastroenterol Hepatol. 2005. PMID: 15836702
Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice.
Crespo J, Cabezas J, Sacristán B, Olcoz JL, Pérez R, De la Vega J, García R, García-Pajares F, Sáez-Royuela F, González JM, Jiménez F, Rodríguez S, Cuadrado A, López-Arias MJ, García I, Milla A, García-Riesco E, Muñoz M, Sánchez-Antolín G, Jorquera F. Crespo J, et al. Among authors: olcoz jl. Liver Int. 2015 Feb;35(2):401-8. doi: 10.1111/liv.12536. Epub 2014 Apr 9. Liver Int. 2015. PMID: 24650000
[Glutaraldehyde colitis].
Espinel J, Pinedo E, Bailador C, Herrera A, Domínguez A, Olcoz JL. Espinel J, et al. Among authors: olcoz jl. Rev Esp Enferm Dig. 2006 Feb;98(2):149-50. doi: 10.4321/s1130-01082006000200014. Rev Esp Enferm Dig. 2006. PMID: 16566650 Free article. Spanish. No abstract available.
Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy.
Sáez-Royuela F, Linares P, Cervera LA, Almohalla C, Jorquera F, Lorenzo S, García I, Karpman G, Badia E, Vallecillo MA, Moncada A, Calvo S, Olcoz JL; Castile and Leon Hepatology Association (ACyLHE). Sáez-Royuela F, et al. Among authors: olcoz jl. Eur J Gastroenterol Hepatol. 2016 Mar;28(3):305-12. doi: 10.1097/MEG.0000000000000533. Eur J Gastroenterol Hepatol. 2016. PMID: 26636405
44 results